EVOFEM BIOSCIENCES, INC. (EVFM) Operating cash flow 2016–2025
EVOFEM BIOSCIENCES, INC. (EVFM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.0MFY2025 · since FY2016: -$16.3M → -$2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.0M | +48.7% |
| FY2024 | -$3.9M | +56.7% |
| FY2023 | -$9.0M | +87.3% |
| FY2022 | -$70.4M | +52.0% |
| FY2021 | -$146.7M | -39.9% |
| FY2020 | -$104.8M | -90.3% |
| FY2019 | -$55.1M | +2.5% |
| FY2018 | -$56.5M | -193.6% |
| FY2017 | -$19.2M | -18.4% |
| FY2016 | -$16.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EVFM financial trends
EVFM RevenueEVFM Net incomeEVFM Net marginEVFM Gross profitEVFM Gross marginEVFM Operating incomeEVFM Operating marginEVFM Free cash flowEVFM Capital expendituresEVFM Return on equityEVFM Stock buybacksEVFM Dividends paidEVFM Total assetsEVFM Total liabilitiesEVFM Shareholders’ equityEVFM overview →